Loading Page..

Knowledge Content Library

Simulation of the Portfolio of COVID-19 Vaccines

Pharma Interest Group Meeting: Speakers: Vladimir Shnaydman and Jack Scannell
May 21, 2020

Vladimir and Jack discuss the use of probabilistic methods and simulation to explore the likelihood of success of the portfolio of COVID-19 vaccination efforts underway around the world.

Click here for access to the full video.

SDP membership is required for full access to this presentation.

Keywords: Risk and Uncertainty riskunc, Risk analysis riskanal, Analysis and modeling anamod, Probability assessment probass, Monte Carlo simulation mcsim, portfolio decision analysis portda

   Email Print

Stay connected